[Vascular smooth muscle cells in coronary heart disease].
Yoshioka
Shiro
S
Division of Endocrinology/Metabolism, Neurology, and Hematology/Oncology, Department of Clinical Molecular Medicine, Kobe University Graduate School of Medicine.
Tsukamoto
Tatsuo
T
Chihara
Kazuo
K
D003324:Coronary Artery Disease / Q000188:drug therapy / Q000209:etiology* / Q000473:pathology*; D016207:Cytokines / Q000502:physiology; D006133:Growth Substances / Q000502:physiology; D006801:Humans; D008077:Lipoproteins, LDL / Q000378:metabolism; D009131:Muscle, Smooth, Vascular / Q000378:metabolism / Q000473:pathology* / Q000503:physiopathology; D018384:Oxidative Stress; D011973:Receptors, LDL / Q000378:metabolism; D051131:Receptors, Oxidized LDL; D051127:Scavenger Receptors, Class E
D016207:Cytokines; D006133:Growth Substances; D008077:Lipoproteins, LDL; C495137:OLR1 protein, human; D011973:Receptors, LDL; D051131:Receptors, Oxidized LDL; D051127:Scavenger Receptors, Class E; C099252:oxidized low density lipoprotein